Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,702Revenue (TTM) $M10,029Net Margin (%)-22.7Altman Z-Score0.2
Enterprise Value $M35,615EPS (TTM) $-6.6Operating Margin %-5.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-23.2Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %18.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales0.65-y EBITDA Growth Rate %87.0Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow3.1y-y EBITDA Growth Rate %-28.5ROA % (ttm)-4.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-41.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M348ROIC % (ttm)-1.1Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VRX is held by these investors:



VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Thomas W. Sr.Director 2016-12-14Buy5,000$14.7311.34view
Pershing Square Capital ManageDirector 2016-12-12Sell3,476,690$14.8510.44view
KARABELAS ARGERIS NDirector 2016-08-11Buy4,000$24.65-33.47view
Ross Thomas W. Sr.Director 2016-06-13Buy4,000$24.4-32.79view
PAPA JOSEPH CCHAIRMAN & CEO 2016-06-10Buy202,000$24.48-33.01view
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.48-79.1view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-90.97view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-92.55view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-92.71view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-93.55view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
This Guru Loves Valeant; Should You? Feb 20 2017 
Francis Chou Adds to Valeant, Trims Sears in 4th Quarter Feb 16 2017 
Bill Ackman Expands Chipotle Position, Cuts Zoetis Feb 15 2017 
John Paulson's Bargain Stock Jan 30 2017 
How to Diversify Without Selling Stocks You Already Own and Love Jan 29 2017 
Ackman, Berkowitz May Not Get Their Fannie Mae Payout So Fast Under Trump Jan 27 2017 
A Fond Farewell Jan 21 2017 
23 Questions With Adam Strauss of Appleseed Fund Dec 28 2016 
Biotech Stocks to Watch After Senate Drug Report Dec 27 2016 
Bill Ackman Reduces Valeant Stake to Benefit Clients Dec 14 2016 

More From Other Websites
Valeant Acquires Eyegate Licensing Rights Feb 21 2017
​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal Feb 21 2017
Tuesday’s Top Biopharma Movers Feb 21 2017
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan,... Feb 21 2017
EyeGate Pharma surges 15% on news of Valeant licensing agreement Feb 21 2017
EyeGate Pharma surges 15% on news of Valeant licensing agreement Feb 21 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product... Feb 21 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product... Feb 21 2017
This Guru Loves Valeant; Should You? Feb 20 2017
[$$] Unilever was a deal too far for Kraft Heinz Feb 20 2017
Sequoia's Foundation Looks Stronger Than It Was Before Feb 19 2017
Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S. Feb 17 2017
AstraZeneca Stock Rises On Successful Breast Cancer Drug Trial Feb 17 2017
Francis Chou Adds to Valeant, Trims Sears in 4th Quarter Feb 16 2017
Billionaire Bill Ackman’s Pershing Square Boosts Bet on Fast Food Industry, Cuts Down on... Feb 16 2017
Why This FDA Approval for Valeant Is Not as Good as First Thought Feb 16 2017
New Valeant Approval is a Surprise Irritant Feb 16 2017
Valeant Pharmaceuticals: Dead in the Water? Feb 16 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)